Literature DB >> 10839646

Osteoporosis and African American women.

A D Bohannon1.   

Abstract

The incidence of osteoporosis and related fractures in African American women is half that of Caucasian women. African American women who sustain osteoporosis-related fractures have increased disability and decreased survival. Given the exponential increase in hip fracture rate among African American women over the age of 70 years, the risk of osteoporosis among this population may be underestimated. This review focuses on racial differences in women's bone mineral density (BMD) and bone metabolism and on various explanations for these observed differences. Environmental risk factors for osteoporosis and related fractures among African American women and modalities for prevention and treatment of osteoporosis are discussed. African American women begin menopause with higher BMD and have lower rates of women's bone loss after menopause, which account for their decreased incidence of osteoporosis and related fractures. The risk factors for osteoporosis among African American women are similar to those found in Caucasian women. Lifestyle interventions, such as calcium and vitamin D supplementation, smoking cessation, and increased physical activity, should be encouraged to enhance peak bone mass and to decrease bone loss. These interventions and other treatment modalities, such as hormone replacement therapy, bisphosphonates, and selective estrogen receptor modulators, should be studied further in African American women.

Entities:  

Mesh:

Year:  1999        PMID: 10839646     DOI: 10.1089/jwh.1.1999.8.609

Source DB:  PubMed          Journal:  J Womens Health Gend Based Med        ISSN: 1524-6094


  17 in total

1.  Disparities in osteoporosis screening between at-risk African-American and white women.

Authors:  Redonda G Miller; Bimal H Ashar; Jennifer Cohen; Melissa Camp; Carmen Coombs; Elizabeth Johnson; Christine R Schneyer
Journal:  J Gen Intern Med       Date:  2005-09       Impact factor: 5.128

2.  Smokeless tobacco use accelerates age-related loss of bone mineral density among older women in a multi-ethnic rural community.

Authors:  Sara A Quandt; John G Spangler; L Douglas Case; Ronny A Bell; Amy E Belflower
Journal:  J Cross Cult Gerontol       Date:  2005-06

Review 3.  Bisphosphonate therapy for women with breast cancer and at high risk for osteoporosis.

Authors:  Gloria J Morris; Edith P Mitchell
Journal:  J Natl Med Assoc       Date:  2007-01       Impact factor: 1.798

4.  Bone health in immigrant Hispanic women living in Texas.

Authors:  Joyce E Ballard; Cheryl M Cooper; Mary A Bone; Guillermo Saade; David B Holiday
Journal:  J Community Health       Date:  2010-10

5.  Soluble CD14 and fracture risk.

Authors:  M Bethel; P Bůžková; H A Fink; J A Robbins; J A Cauley; J Lee; J I Barzilay; D I Jalal; L D Carbone
Journal:  Osteoporos Int       Date:  2015-12-11       Impact factor: 4.507

6.  Osteoporosis screening is unjustifiably low in older African-American women.

Authors:  Consuelo H Wilkins; Jason S Goldfeder
Journal:  J Natl Med Assoc       Date:  2004-04       Impact factor: 1.798

7.  Vitamin-D nutrition and bone mass in adolescent black girls.

Authors:  Sonia A Talwar; Jane Swedler; James Yeh; Simcha Pollack; John F Aloia
Journal:  J Natl Med Assoc       Date:  2007-06       Impact factor: 1.798

8.  The A563T variation of the renal epithelial calcium channel TRPV5 among African Americans enhances calcium influx.

Authors:  Tao Na; Wei Zhang; Yi Jiang; Youyou Liang; He-Ping Ma; David G Warnock; Ji-Bin Peng
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-04

9.  Spondylolysis and spondylolisthesis: a narrative review of etiology, diagnosis, and conservative management.

Authors:  Daniel W Haun; Norman W Kettner
Journal:  J Chiropr Med       Date:  2005

10.  Association between a literature-based genetic risk score and bone mineral density of African American women in Women Health Initiative Study.

Authors:  X Xiao; Q Wu
Journal:  Osteoporos Int       Date:  2019-12-01       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.